LYTIR

Insider · SEC Form 4 · Director

PERCEPTIVE ADVISORS LLC

In the 12 months to Nov 19, 2026, on the open market: bought $7.5M of IMTX. Filed 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. IMTXBought: Immatics N.V. Aug 26, 2026 863,060 shares filed Aug 27, 2026 11,246,516 shares held indirectly after, as filed filing $7.5M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Stakes filed (13D/13G)

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G

  1. TRIBPerceptive Advisors LLC filed Nov 10, 2026 Schedule 13D/A may seek influence 54,148,590 shares issuer: Trinity Biotech plc filing 9.99%
  2. NAUTPerceptive Advisors LLC filed Nov 3, 2026 Schedule 13D/A may seek influence 4,944,512 shares issuer: Nautilus Biotechnology, Inc. filing 3.9%
  3. LONAPerceptive Advisors LLC filed Oct 26, 2026 Schedule 13D/A may seek influence 1,889,403 shares issuer: LeonaBio, Inc. filing 19.99%
  4. QNCXPerceptive Advisors LLC filed Oct 14, 2026 Schedule 13G passive issuer: IRulya Therapeutics Inc. filing 8.4%
  5. KARDPerceptive Advisors LLC filed Oct 1, 2026 Schedule 13D/A may seek influence 8,254,144 shares issuer: Kardigan, Inc. filing 8.8%
  6. NRIXPerceptive Advisors LLC filed Sep 23, 2026 Schedule 13G passive issuer: Nurix Therapeutics, Inc. filing 5.3%
  7. IMTXPERCEPTIVE ADVISORS LLC filed Aug 27, 2026 Schedule 13D/A may seek influence 11,418,016 shares issuer: Immatics N.V. filing 7.6%
  8. LONAPERCEPTIVE ADVISORS LLC filed Aug 25, 2026 Schedule 13D/A may seek influence 1,889,403 shares issuer: LeonaBio, Inc. filing 19.99%
  9. SLDBPERCEPTIVE ADVISORS LLC filed Aug 14, 2026 Schedule 13D/A may seek influence 12,046,579 shares issuer: Solid Biosciences Inc. filing 11.2%
  10. IRDPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: Opus Genetics, Inc. filing 9.99%
  11. ENGNPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: enGene Holdings Inc. filing 9.99%
  12. ANROPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: Alto Neuroscience, Inc. filing 9.99%
  13. INBXPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: INHIBRX BIOSCIENCES, INC. filing 9.99%
  14. NAUTPERCEPTIVE ADVISORS LLC filed Aug 14, 2026 Schedule 13D/A may seek influence 11,634,211 shares issuer: Nautilus Biotechnology, Inc. filing 9.1%
  15. XFORPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: X4 PHARMACEUTICALS, INC. filing 8.1%
  16. STROPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: SUTRO BIOPHARMA, INC. filing 7.9%
  17. SABSPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: SAB BIOTHERAPEUTICS, INC. filing 7.3%
  18. IKTPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: INHIBIKASE THERAPEUTICS, INC. filing 6.9%
  19. IVVDPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: INVIVYD, INC. filing 6.3%
  20. BLSMPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G passive issuer: BlossomHill Therapeutics, Inc. filing 5.9%
  21. SYREPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: SPYRE THERAPEUTICS, INC. filing 4.9%
  22. TENXPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: Tenax Therapeutics, Inc. filing 4.5%
  23. NVNOPerceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive issuer: enVVeno Medical Corporation filing 3.5%
  24. KPRXPerceptive Advisors LLC filed Aug 10, 2026 Schedule 13G passive issuer: KIORA PHARMACEUTICALS, INC. filing 9.99%
  25. RLAYPerceptive Advisors LLC filed Aug 10, 2026 Schedule 13G/A passive issuer: RELAY THERAPEUTICS, INC. filing 6.4%
  26. VYNEPerceptive Advisors LLC filed Aug 3, 2026 Schedule 13G passive issuer: Yarrow Bioscience, Inc. filing 9.99%
  27. FRNMPERCEPTIVE ADVISORS LLC filed Jul 23, 2026 Schedule 13G passive issuer: Freenome, Inc. filing 10.1%
  28. RACDPERCEPTIVE ADVISORS LLC filed Jul 20, 2026 Schedule 13G passive issuer: Research Alliance Corp IV filing 7.7%
  29. KARDPERCEPTIVE ADVISORS LLC filed Jun 25, 2026 Schedule 13D may seek influence 8,254,144 shares issuer: Kardigan, Inc. filing 8.9%

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • FRNM: grant or award (code A), 1 entry, Jul 20, 2026
  • KARD: grant or award (code A), 1 entry, Jun 17, 2026
  • LONA: option exercise or conversion (code M), 1 entry, Oct 26, 2026
Code A
A grant or award from the company, such as stock given as pay.
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.